8-K
Current Report
Kairos Pharma, LTD. Filed Acc 0001641172-25-014905
Material agreement · Shareholder vote results
- Item 1.01 Entry into a material definitive agreement
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading form8-k.htm…